Home › Companies › Biotechnology, Genetics, Health Care, Lifestyle, Pharmaceutical, Therapeutics › Mirnext
Mirnext
Mirnext focuses on the discovery, validation, and commercialization of miRNAs as novel biomarkers for cardiovascular disease.
Operating in biotechnology, genetics, health care, lifestyle, pharmaceutical, therapeutics based in European Union (EU), Europe, Middle East, and Africa (EMEA), Mirnext was founded in 2012.
The company sits in the biotechnology, genetics, health care, lifestyle, pharmaceutical, therapeutics segment, where it competes on its core product or service.
European Union (EU), Europe, Middle East, and Africa (EMEA) is where the company is located.
Its current recorded stage is Series_Unknown.
Recorded headcount: c_00001_00010 employees.
| Sector | Biotechnology, Genetics, Health Care, Lifestyle, Pharmaceutical, Therapeutics |
|---|---|
| Headquarters | European Union (EU), Europe, Middle East, and Africa (EMEA) |
| Founded | 2012 |
| Employees | c_00001_00010 |
| Stage | series_unknown |
Website: www.mirnext.com
Browse related
Contact details and direct channels are available to signed-in members.
Create a free account
Create a free account